We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
NETGEAR
NTGR
$635M
| $2.8M | ﹤0.01% |
87,767
-10,603
| -11% | -$368K |
|
1702
Vir Biotechnology
VIR
$1.49B
| $2.8M | ﹤0.01% |
64,334
+1,383
| +2% | +$59.9K |
|
1703
Ichor Holdings
ICHR
$2.56B
| $2.8M | ﹤0.01% |
68,096
-9,994
| -13% | -$456K |
|
1704
PTC Therapeutics
PTCT
$6.12B
| $2.79M | ﹤0.01% |
75,041
-809
| -1% | -$33.2K |
|
1705
Bloom Energy
BE
$64.6B
| $2.79M | ﹤0.01% |
148,908
+349
| +0.2% | +$7.38K |
|
1706
Magnolia Oil & Gas
MGY
$5.94B
| $2.79M | ﹤0.01% |
156,678
+5,958
| +4% | +$90.1K |
|
|
CVA
1707
DELISTED
Covanta Holding Corporation
CVA
| $2.78M | ﹤0.01% |
138,350
+3,789
| +3% | +$74.9K |
|
1708
Laureate Education
LAUR
$5.28B
| $2.78M | ﹤0.01% |
163,674
-3,523
| -2% | -$55.4K |
|
|
DCH
1709
Dauch Corp
DCH
$1.51B
| $2.77M | ﹤0.01% |
314,573
-40,948
| -12% | -$375K |
|
|
KRTX
1710
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.77M | ﹤0.01% |
22,650
+539
| +2% | +$62.2K |
|
1711
MGP Ingredients
MGPI
$375M
| $2.77M | ﹤0.01% |
42,512
-2,332
| -5% | -$149K |
|
|
PGRE
1712
DELISTED
Paramount Group
PGRE
| $2.77M | ﹤0.01% |
307,682
+7,107
| +2% | +$65.8K |
|
|
MNR
1713
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $2.76M | ﹤0.01% |
147,842
+2,713
| +2% | +$51.4K |
|
1714
Usana Health Sciences
USNA
$286M
| $2.74M | ﹤0.01% |
29,735
-4,081
| -12% | -$393K |
|
|
CLR
1715
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $2.74M | ﹤0.01% |
59,298
-5,629
| -9% | -$212K |
|
1716
Mativ Holdings
MATV
$711M
| $2.74M | ﹤0.01% |
78,952
-11,256
| -12% | -$420K |
|
1717
Marcus & Millichap
MMI
$1.19B
| $2.72M | ﹤0.01% |
66,894
-7,651
| -10% | -$297K |
|
|
BRSL
1718
Brightstar Lottery PLC
BRSL
$2.03B
| $2.71M | ﹤0.01% |
102,937
+2,996
| +3% | +$63.5K |
|
|
ECOL
1719
DELISTED
US Ecology, Inc.
ECOL
| $2.71M | ﹤0.01% |
83,616
-12,379
| -13% | -$445K |
|
|
TWOU
1720
DELISTED
2U Inc
TWOU
| $2.7M | ﹤0.01% |
2,682
+99
| +4% | +$116K |
|
|
TVTY
1721
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $2.7M | ﹤0.01% |
117,123
-5,808
| -5% | -$138K |
|
1722
Universal Corp
UVV
$1.27B
| $2.69M | ﹤0.01% |
55,729
-9,381
| -14% | -$476K |
|
|
SI
1723
DELISTED
Silvergate Capital Corporation
SI
| $2.69M | ﹤0.01% |
23,309
+1,789
| +8% | +$192K |
|
|
CHCT
1724
Community Healthcare Trust
CHCT
$454M
| $2.69M | ﹤0.01% |
59,554
-7,808
| -12% | -$379K |
|
|
POLY
1725
DELISTED
Plantronics, Inc.
POLY
| $2.69M | ﹤0.01% |
104,659
-4,235
| -4% | -$133K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.